Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eiger BioPharmaceuticals, Inc. - Common Stock (NQ:EIGR)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eiger BioPharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
EIGER ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint
Via Benzinga
Eiger BioPharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Eiger BioPharmaceuticals Announces Leadership Change
From Eiger BioPharmaceuticals, Inc.
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
From Rosen Law Firm
Via Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
How Is The Market Feeling About Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals's (NASDAQ:EIGR) short percent of float has fallen 8.23% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 4.57% of all... 
Via Benzinga
S&P 500 Rises 0.5%; Ciena Posts Upbeat Q4 Results
U.S. stocks traded higher toward the end of trading, with the NASDAQ gaining around 100 points on Thursday. 
Via Benzinga
Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Gains 100 Points; Rent the Runway Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Thursday. 
Via Benzinga
Eiger BioPharmaceuticals' Debt Overview
Shares of Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR) decreased by 85.08% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to... 
Via Benzinga
Dow Rises 150 Points; US Jobless Claims Increase To 230,000
U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SolarEdge, Eiger, Unisys, and Rent the Runway and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
NASDAQ:EIGR Shareholder Notice: Lawsuit Alleges Misleading Statements by Eiger BioPharmaceuticals, Inc.
San Diego, CA -- (SBWIRE) -- 11/30/2022 -- An investor, who purchased shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), filed a lawsuit against Eiger BioPharmaceuticals, Inc over alleged... 
Via SBWire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eiger BioPharmaceuticals, Inc. (EIGR)
From Glancy Prongay & Murray LLP
Via Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Eiger BioPharmaceuticals, Inc. (EIGR) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.